Overview:

The General Compliance Program Guidance (GCPG), released by the Department of Health and Human Services Office of Inspector General (OIG) in November 2023, serves as a foundational resource for the entire healthcare compliance community. This guidance reflects the significant evolution in both compliance programs and the healthcare landscape since the last major update in 2005.

The GCPG offers a comprehensive framework covering relevant federal laws, compliance infrastructure, and OIG resources. This session will dissect the new guidance, translating its implications for modern compliance programs—from board oversight and committee structures to risk assessment protocols—and provide actionable strategies for implementation.

Adherence to this guidance is critical for fostering a culture of integrity and ethical conduct while systematically mitigating risks related to fraud, waste, and abuse. Organizations must now tailor their compliance programs to their specific operational profile, informed by these updated regulatory expectations.

Learning Objectives:

This webinar will provide a detailed analysis of the OIG's November 2023 GCPG, enabling attendees to:

• Comprehend the purpose and practical application of the new guidance.

• Identify and review the key federal regulations referenced within the GCPG.

• Learn to utilize the tools and resources presented in the document effectively.

• Apply the guidance to strengthen each of the seven fundamental elements of a compliance program.

• Leverage the valuable references and hyperlinks provided in the GCPG for ongoing compliance management.

The session will conclude with a live Q&A, providing an opportunity to address specific organizational challenges.

Why Should You Attend:

This webinar is essential for any professional responsible for navigating the complexities of healthcare compliance. The GCPG represents the OIG's current perspective on establishing effective systems to ensure adherence to laws, regulations, and ethical standards.

Participation offers a critical opportunity to gain insights directly aligned with regulatory expectations, network with peers, and demonstrate a proactive commitment to compliance. Staying informed with this guidance is a strategic necessity to mitigate risk, ensure regulatory adherence, and protect your organization's reputation and financial stability.

Who Should Attend:

This guidance is pertinent to a wide range of healthcare stakeholders, including:

• Executive Leadership: Healthcare CEOs, CFOs, COOs, and General Counsel.

• Compliance Leadership: Chief Compliance Officers, Privacy Officers, and Compliance Analysts.

• Provider Organizations: Hospitals, Home Health Agencies, Hospices, Nursing Facilities, and Clinical Laboratories.

• Suppliers & Manufacturers: Durable Medical Equipment suppliers, Pharmaceutical Manufacturers, and Ambulance suppliers.

• Service Entities: Third-Party Medical Billing Companies, Medicare Advantage Organizations, and Business Associates.